Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Continuous heart rate variability from an implanted device: a practical guide for clinical use.

Philip B Adamson1

  • 1Heart Failure Institute, Oklahoma Cardiovascular Associates/Oklahoma Heart Hospital, Oklahoma City, OK 73120, USA. padamson@ocaheart.com

Congestive Heart Failure (Greenwich, Conn.)
|December 7, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baroreflex Activation Therapy In Heart Failure-the Barostim-Enabled Neurohormonal Intervention for Improving Treatment of Heart Failure (BENEFIT-HF) Trial Rationale and Design.

Journal of cardiac failure·2026
Same author

Social Drivers of Health in Heart Failure Trials: An Analysis From the Heart Failure Collaboratory.

JACC. Heart failure·2025
Same author

Patients report increased control and decreased impact of heart failure during pulmonary pressure-guided management.

ESC heart failure·2025
Same author

Real-World Analysis of Health Care Utilization With Baroreflex Activation Therapy for Heart Failure.

Journal of cardiac failure·2025
Same author

Remote haemodynamic-guided heart failure management in France: Results from the CardioMEMS HF System Post-Market Study (COAST) French cohort.

Archives of cardiovascular diseases·2024
Same author

Clinical Trial Inclusion and Impact on Early Adoption of Medical Innovation in Diverse Populations.

JACC. Heart failure·2024

Continuous heart rate variability monitoring from implanted devices can predict worsening heart failure. This data offers insights into autonomic control, aiding chronic heart failure management and potentially reducing hospitalizations.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Clinical Medicine

Background:

  • Continuous heart rate variability (HRV) monitoring is feasible with implanted devices.
  • HRV reflects autonomic nervous system control of the heart.
  • Autonomic dysfunction is prevalent in chronic heart failure (CHF).

Purpose of the Study:

  • To review clinical evidence for HRV use in CHF management.
  • To propose practical clinical applications for continuous HRV data.
  • To explore HRV as a predictor of clinical events in CHF.

Main Methods:

  • Review of existing clinical studies on HRV in CHF.
  • Analysis of HRV metrics derived from implanted electronic devices.
  • Correlation of HRV changes with patient clinical status and outcomes.

Related Experiment Videos

Main Results:

  • Continuous HRV measurements provide insights into cardiac autonomic control status.
  • Changes in HRV, along with atrial activation variability, predict decompensation and hospitalization risk.
  • These markers may offer early warnings for adverse events in CHF patients.

Conclusions:

  • Continuous HRV monitoring from implanted devices is a valuable tool for CHF management.
  • HRV metrics can serve as predictive markers for clinical deterioration.
  • Further prospective trials are needed to confirm the impact on healthcare utilization.